OncoHost
Israel, IL · Founded 2017 · 43 employees on LinkedIn · 2 known investors
Find your way into OncoHost
742 people in our graph share verified history with the OncoHost team — schools, employers, funds. One of them is your warm intro.
Arnon Dinurunlockedknows Ofer Sharon · together at Tel Aviv University (overlapped)
×4knows the team · via Tel Aviv University
×4knows the team · via Technion
×3knows the team · via AstraZeneca
OncoHost develops the PROphet platform, a precision medicine diagnostic tool combining proteomics, bioinformatics, and machine learning to help oncologists predict patient response to cancer therapies and select optimal treatment. The company serves clinicians and cancer patients worldwide with biomarker-driven insights to overcome treatment resistance.
Founders & leadership
OncoHost was founded in 2017 by Yuval Shaked.
YS
Yuval ShakedinCo-Founder & Chief Scientific AdvisorYuval Shaked is a professor at the Rappaport Faculty of Medicine and Head of the Technion Integrated Cancer Center who co-founded OncoHost, where he serves as Chief Scientific Advisor. His research focuses on host response mechanisms in cancer therapy and he advises multiple pharmaceutical and biotech companies.
OS
Ofer SharoninCEOOfer Sharon is a physician and entrepreneur who has founded multiple life-science and digital-health companies over two decades, with experience in clinical development, market access, and precision-oncology diagnostics. He leads OncoHost, which develops the PROphet platform, a proteomics-based diagnostic tool for predicting cancer treatment response.
Investors · 2
Funding
SEC filings, press & company announcements$35M disclosed across 1 of 4 rounds · 2021–2022
- Undisclosed amountSeries CMay 2022Source ↗
- $35MraisedMay 2022 · 2 sourcesSource ↗
- Undisclosed amountSeries BJan 2021Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does OncoHost do?
- OncoHost develops the PROphet platform, a precision medicine diagnostic tool combining proteomics, bioinformatics, and machine learning to help oncologists predict patient response to cancer therapies and select optimal treatment. The company serves clinicians and cancer patients worldwide with biomarker-driven insights to overcome treatment resistance.
- Who founded OncoHost?
- OncoHost was founded by Yuval Shaked in 2017.
- Who are OncoHost's investors?
- OncoHost's investors include ALIVE Israel HealthTech Fund, OurCrowd.
- How much funding has OncoHost raised?
- OncoHost has disclosed $35M raised across 1 of its 4 known rounds.
- Where is OncoHost headquartered?
- OncoHost is headquartered in Israel, IL.